Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Healthtrust
Accenture
Covington
Fuji
Baxter
McKinsey
Queensland Health
US Army

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 060764

« Back to Dashboard

NDA 060764 describes NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, which is a drug marketed by Akorn, Bausch And Lomb, and Perrigo Co Tennessee, and is included in three NDAs. It is available from thirteen suppliers. Additional details are available on the NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC profile page.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC is bacitracin zinc; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the bacitracin zinc; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 060764
Pharmacology for NDA: 060764
Suppliers and Packaging for NDA: 060764
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 060764 ANDA Paddock Laboratories, LLC 0574-4250 0574-4250-35 1 TUBE in 1 CARTON (0574-4250-35) > 3.5 g in 1 TUBE
NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 060764 ANDA Putney, Inc. 26637-841 26637-841-41 1 TUBE in 1 CARTON (26637-841-41) > 3.5 g in 1 TUBE

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;OPHTHALMICStrength400 UNITS/GM;EQ 3.5MG BASE;10,000 UNITS/GM
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
Citi
Teva
Chubb
Novartis
Daiichi Sankyo
Fish and Richardson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot